Figure 3.
Mean plasma sTNF-RII levels over 12 months by chemotherapy exposure status. Comparisons between chemotherapy exposed (dotted line) and no chemotherapy (solid line) treatment groups, controlling for age, BMI, and radiation, showed significantly higher levels of sTNF-RII in the chemotherapy treated group at T1 and T2.